We are seeking a Research Project Advisor to support our Community Outreach and Engagement program! Applicants should have a BS or MS in Biomedical Sciences, Public Health, Research, or related field & 7+ years in research program & project support. jobs.cshs.org#en/sites/CX_...

Do you have metastatic triple negative breast cancer #TNBC that has grown or spread after treatment? You may be eligible for the #YUANTNBC clinical trial. Follow the link below or call (414)-314-0471 to learn more.

Alessio Pigazzi, expert in robot-assisted techniques, selected as new colorectal surgery leader at Cedars-Sinai (@cedarssinaicancer.bsky.social) https://cancerletter.com/in-brief/20251003_8c/

The Cedars-Sinai Cancer: Adolescents and Young Adult Cancer Conference will take place on 10/11 at the Marina Del Rey Marriott with updates on best practices for multi-disciplinary management of adolescent and young adult cancer. cedars.cloud-cme.com/course/cours...

Do you have EGFR-Mutated #NonSmallCellLungCancer and are considering treatment? You may be eligible for the #Copernicus clinical trial. Follow the link below or call (424)-312-0745 to learn more. clinicaltrials.cedars-sinai.edu/view/6118637...

Our fourth cohort of Undergraduates Gaining Research Opportunities for the Cancer Workforce (U-GROW) Program research internships was completed this summer! Congratulations to all of the promising young researchers!

We’ re proud our Cancer Research Training and Education Coordination Office in partnership with YMCA Metro LA held the Beyond the Books: High School Healthcare Career Exploration Program this summer with 24 high school students learning about cancer research!

We are seeking a Research Project Advisor to support our Community Outreach and Engagement program! Applicants should have a BS or MS in Biomedical Sciences, Public Health, Research, or related field & 7+ years in research program & project support. jobs.cshs.org#en/sites/CX_...

Check the latest cancer-related publications from Cedars-Sinai and Cedars-Sinai Cancer clinicians and researchers! Follow this link on LinkedIn for a listing of these cutting-edge research papers. www.linkedin.com/posts/cedars...

Cedars-Sinai Cancer clinicians and researchers are sharing their expertise in a variety of interviews and articles on a wide range of topics! Follow this link on LinkedIn to see the latest news on their work. www.linkedin.com/pulse/cedars...

Do you have EGFR-Mutated #NonSmallCellLungCancer and are considering treatment? You may be eligible for the #Copernicus clinical trial. Follow the link below or call (424)-312-0745 to learn more. clinicaltrials.cedars-sinai.edu/view/6118637...

What is the prevalence of #BRCA pathogenic or likely (P/LP) variants in an unselected population of women with #breastcancer? Via @jamanetworkopen.com @cedarssinaicancer.bsky.social #hereditarycancer #BCSM #womenshealth #genetics #cancerresearch #medsky

Fab closing presentation by friend and #mathonco agitator @gliomath.bsky.social from @cedarssinaicancer.bsky.social presenting cool new work, Every Patient Deserves Their Own Equation: Towards Digital Twins for Neuro-Oncology.

ER-positive, HER2-negative is the most common subtype of breast cancer. Learn more about prevention, screening, and treatment options for breast: buff.ly/dYFDLF1

We are proud to have Cedars Sinai recognized in the Honor Roll of the U.S. News & World Report's Annual "Best Hospitals" Rankings for the 10th consecutive year and tied for #1 in California and #1 in Los Angeles! @usnews.com www.cedars-sinai.org/newsroom/ced...

Do you have EGFR-Mutated #NonSmallCellLungCancer and are considering treatment? You may be eligible for the #Copernicus clinical trial. Follow the link below or call (424)-312-0745 to learn more. clinicaltrials.cedars-sinai.edu/view/6118637...

We are seeking a Research Project Advisor to support our Community Outreach and Engagement program! Applicants should have a BS or MS in Biomedical Sciences, Public Health, Research, or related field & 7+ years in research program & project support. jobs.cshs.org#en/sites/CX_...

Cedars-Sinai Cancer clinicians and researchers will be at The American Society for Radiation Oncology (ASTRO) 2025 Annual Meeting 9/27-10/1! See the highlight schedule for their presentations and activities at the meeting. @astro-org.bsky.social #ASTRO25

Do you have metastatic triple negative breast cancer #TNBC that has grown or spread after treatment? You may be eligible for the #YUANTNBC clinical trial. Follow the link below or call (414)-314-0471 to learn more. clinicaltrials.cedars-sinai.edu/view/IIT2022...

Ze’ev Ronai, MD: "We simply did not realize how important the environment is for tumor development and the enormous role played by immune responses and the tumor microenvironment." https://cancerletter.com/guest-editorial/20250912_2/

Dr. Vladimir Ljubimov is first author on the Journal of Controlled Release paper describing a new therapeutic system developed with the help of AI that significantly improved survival of laboratory mice with primary central nervous system lymphoma. www.cedars-sinai.org/newsroom/ai-...

Do you have EGFR-Mutated #NonSmallCellLungCancer and are considering treatment? You may be eligible for the #Copernicus clinical trial. Follow the link below or call (424)-312-0745 to learn more. clinicaltrials.cedars-sinai.edu/view/6118637...

The International Association for the Study of Lung Cancer @iaslc.bsky.social Lung Cancer News covered the results of the Phase III Pragmatica-Lung trial presented at the 2025 ASCO @ascocancer.bsky.social annual meeting by Dr. Karen Reckamp. www.ilcn.org/a-pragmatic-...

Do you have metastatic triple negative breast cancer #TNBC that has grown or spread after treatment? You may be eligible for the #YUANTNBC clinical trial. Follow the link below or call (414)-314-0471 to learn more. clinicaltrials.cedars-sinai.edu/view/IIT2022...

"Look at where our understanding of cancer was...20, or more years ago and then consider what has happened over the past two decades. We finally realized how more complex the problem of cancer is—more than any of us imagined."- Ze’ev Ronai, MD https://cancerletter.com/guest-editorial/20250912_2/

Reflections of a cancer scientist. Guest editorial by Ze’ev Ronai @cedarssinaicancer.bsky.social https://cancerletter.com/guest-editorial/20250912_2/

This summer, our Community Outreach and Engagement program hosted the survivorship event “Communities Overcoming Cancer Together and Facing Life After a Diagnosis” with partners American Cancer Society, Anthem, Blood Cancer United, and the Cancer Support Community. Our thanks to everyone involved!

Do you have metastatic triple negative breast cancer #TNBC that has grown or spread after treatment? You may be eligible for the #YUANTNBC clinical trial. Follow the link below or call (414)-314-0471 to learn more. clinicaltrials.cedars-sinai.edu/view/IIT2022...

Our newsroom shares the extraordinary story of one of our patients who was suffering from a massive 40-pound tumor pressing against her lungs and heart. Dr. Cristina Ferrone brought together a team who successfully removed the tumor after a 14 hour surgery. www.cedars-sinai.org/newsroom/bri...

Do you have EGFR-Mutated #NonSmallCellLungCancer and are considering treatment? You may be eligible for the #Copernicus clinical trial. Follow the link below or call (424)-312-0745 to learn more. clinicaltrials.cedars-sinai.edu/view/6118637...

Dr. Jane Figueiredo is senior author on the JAMA Oncology paper “COVID-19 Vaccine Booster Uptake and Effectiveness Among US Adults with Cancer” showing COVID-19 boosters reduced cancer patients’ hospitalizations and ICU admissions. @jama.com www.cedars-sinai.org/newsroom/can...

The Cedars-Sinai Cancer Division of Hematology and Cellular Therapy has reached the milestone of treating our 100th commercial CAR T-cell therapy patient! They are also expanding cell therapy treatments including TIL therapy for solid tumor malignancies. www.cedars-sinai.org/newsroom/wee...

Do you have metastatic triple negative breast cancer #TNBC that has grown or spread after treatment? You may be eligible for the #YUANTNBC clinical trial. Follow the link below or call (414)-314-0471 to learn more. clinicaltrials.cedars-sinai.edu/view/IIT2022...

Do you have EGFR-Mutated #NonSmallCellLungCancer and are considering treatment? You may be eligible for the #Copernicus clinical trial. Follow the link below or call (424)-312-0745 to learn more. clinicaltrials.cedars-sinai.edu/view/6118637...

Stephen Miller is first author and Dr. Katelyn Atkins is senior author on the Clinical Journal of Oncology Nursing paper showing a primary nursing care model in radiation oncology can result in improved overall quality outcomes. www.ons.org/publications...

In Cedars-Sinai Research Tips - Dr. Taylon Silva is first author and Dr. Dolores Di Vizio @doldivizio is corresponding author on the @CellRepMed paper describing a method to improve yields of cancer-specific extracellular vesicles. ‪ @cp-cellreports.bsky.social www.cedars-sinai.org/newsroom/res...

In Cedars-Sinai Research Tips – Dr. Bin Zheng is senior author on the Nature Communications paper “DHODH Modulates Immune Evasion of Cancer Cells via CDP-Choline Dependent Regulation of Phospholipid Metabolism and Ferroptosis.” @nature.com www.cedars-sinai.org/newsroom/res...

In Cedars-Sinai Research Tips – Dr. Ju Dong Yang is senior author on the Heptaology paper “Comparative Effectiveness of Immunotherapy versus Lenvatinib in Advanced Hepatocellular Carcinoma: A Real-World Analysis Using Target Trial Emulation.” www.cedars-sinai.org/newsroom/res...

Dr. Katelyn Atkins is senior author on the Clinical Journal of Oncology Nursing paper demonstrating that a primary #nursing care model in #RadiationOncology can result in improved engagement of nurses and overall #quality outcomes. www.ons.org/publications...

Dr. Leslie Ballas was interviewed by @npr.org's Airtalk on #prostatecancer screening and Dr. Robert Figlin and Dr. Timothy Daskivich were interviewed by Time on progression of the disease and the latest treatments. www.cedars-sinai.org/newsroom/tim...

Dr. Allen Ho is lead author and Dr. Zachary Zumsteg is senior author on the Lancet Oncology paper updating staging guidelines for HPV-positive throat #cancer to improve accuracy and clinical treatments. #HPV www.cedars-sinai.org/newsroom/upd...

The Cedars-Sinai Center for Space Medicine Research has launched with Dr. Arun Sharma @arunsharmaphd.bsky.social serving as the director for the new center. This center has the potential to bring innovative treatments for #cancer as well as other diseases! www.cedars-sinai.org/newsroom/ced...

Dr. Yi-Wen Hsiao is lead author and Dr. Pei-Chen Peng is senior author on the Journal of the NCCN paper that found the PREDICT #breastcancer online tool accurately predicted survival for US patients but was less accurate in some minority groups. www.cedars-sinai.org/newsroom/res...

The Cedars-Sinai Clinical and Regulatory Sciences Certificate Program is a one-year, fully online program ideal for a BA/BS looking for a #career in #biotech, #pharma, #medicaldevices or #clinicalresearch. The application deadline is today! www.cedars-sinai.edu/education/pr...

Dr. Simon Knott and Dr. Dan Theodorescu are senior authors on the @nature.com paper “Concurrent Loss of the Y Chromosome in Cancer and T Cells Impacts Outcome” linking loss of the #Ychromosome in #cancer and immune cells with worse outcomes. www.cedars-sinai.org/newsroom/los...

Dr. Alexandra Gangi and Dr. Shelly Lu are authors on a Cellular and Molecular Gastroenterology and Hepatology paper showing the common #dietary supplement S-adenosylmethionine appears to prevent liver injury in #colorectalcancer patients. @aga-cmgh.bsky.social‬ www.cedars-sinai.org/newsroom/res...

The Cedars-Sinai Clinical and Regulatory Sciences Certificate Program is a one-year, fully online program ideal for a BA/BS looking for a #career in #biotech, #pharma, #medicaldevices or #clinicalresearch. The application deadline is 8/5! www.cedars-sinai.edu/education/pr...

Dr. Alexandra Gangi describes hyperthermic intraperitoneal #chemotherapy (HIPEC) for abdominal #cancers and shares an informational video. Dr. Gangi gives an overview of HIPEC, describing the differences compared to regular chemotherapy. www.cedars-sinai.org/newsroom/wha...

Dr. Jane Figueiredo is co-senior author on the #Cancer Research paper “Colorectal #Tumors in Diverse Patient Populations Feature a Spectrum of Somatic Mutational Profiles” identifying molecular alterations based on genetic ancestry. @aacrjournals.bsky.social www.cedars-sinai.org/newsroom/gen...

Dr. Andrew Hung is senior author on the JAMA Surgery paper “Surgical Performance Metrics for 1-Year Patient-Reported Outcomes After Radical Prostatectomy” examining videos of robotic-assisted prostatectomies to assess technical surgical skills www.cedars-sinai.org/newsroom/a-s...